J&J says it won’t enforce AIDS drug patent in Africa

LONDON (Reuters) – Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson’s HIV/AIDS drug Prezista for sale in Africa and other poor countries. U.S. healthcare group J&J said on Thursday it would not enforce patents, provided generic firms made high-quality versions of the drug – known generically as darunavir – for sub-Saharan Africa and Least Developed Countries. Prezista is a relatively new drug used when patients develop resistance to older antiretrovirals. …

J&J says won’t enforce AIDS drug patent in Africa

LONDON (Reuters) – Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson’s HIV/AIDS drug Prezista for sale in Africa and other poor countries. U.S. healthcare group J&J said on Thursday it would not enforce patents, provided generic firms made high-quality versions of the drug – known generically as darunavir – for sub-Saharan Africa and Least Developed Countries. Prezista is a relatively new drug used when patients develop resistance to older antiretrovirals. …

Hikma looking to bolster presence in Africa

(Reuters) – Jordan’s Hikma Pharmaceuticals Plc said it is looking to expand in Africa over the next two to three years, through building its own plant or by making an acquisition of up to $300 million. The company, which makes and sells branded and generic drugs, said it would be a natural progression to ramp up its presence in the African continent, given that it derives more than half its revenue from the Middle East and North Africa (MENA) region. …

1 2 3 4